NCT03264937View on ClinicalTrials.gov

Social-software iMproving wARfarin Therapy

NACompletedINTERVENTIONAL
Enrollment

735

Participants

Timeline

Start Date

September 1, 2017

Primary Completion Date

March 1, 2019

Study Completion Date

March 8, 2019

Conditions
Anticoagulants Causing Adverse Effects in Therapeutic UsePatient Compliance
Interventions
BEHAVIORAL

Social-software management

Using Wechat application, a social platform, to manage warfarin therapy in patients with mechanical valve replacement.

Trial Locations (1)

430000

WAHH, Wuhan

All Listed Sponsors
lead

Wuhan Asia Heart Hospital

OTHER

NCT03264937 - Social-software iMproving wARfarin Therapy | Biotech Hunter | Biotech Hunter